Serglycin: at the crossroad of inflammation and malignancy
Serglycin has been initially characterized as an intracellular proteoglycan expressed by hematopoietic cells. All inflammatory cells highly synthesize serglycin and store it in granules, where it interacts with numerous inflammatory mediators, such as proteases, chemokines, cytokines and growth fact...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2014-01-01
|
| Col·lecció: | Frontiers in Oncology |
| Matèries: | |
| Accés en línia: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00327/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|